EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Role of Kinases in Neurodegenerative Diseases: From Pathogenesis to Treatment

Alkusha Naim, Azhar Mahmood Farooqui, Badruddeen, Mohammad Irfan Khan, Juber Akhtar, Asad Ahmad, Anas Islam iD

European Journal of Neuroscience · 2025-06 · 61 (11)

DOI: 10.1111/ejn.70156 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Neuroscience, online erschienen am 04.06.2025. Verfasst von Alkusha Naim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Protein Kinases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 160 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases are characterized by progressive neuronal loss and dysfunction, with protein kinases playing crucial roles in their pathogenesis. This article explores the involvement of protein kinases in these disorders, focusing on their contributions to disease mechanisms, potential as therapeutic targets and challenges in developing effective treatments. In Alzheimer's disease, kinases such as CDK5, GSK3β and MARK4 are implicated in tau hyperphosphorylation and the formation of neurofibrillary tangles. Kinases also regulate amyloid‐β processing and plaque formation. In Parkinson's disease, LRRK2, PINK1 and other kinases contribute to α‐synuclein pathology, mitochondrial dysfunction and neuroinflammation. LRRK2 inhibitors and PROTACs have shown promise in preclinical models. Huntington's disease involves altered kinase activity, with CK2, GSK3 and MAPK pathways influencing mutant huntingtin toxicity and aggregation. Kinases are also implicated in less common neurodegenerative diseases, such as ALS and spinocerebellar ataxias. Despite the therapeutic potential of targeting kinases, challenges remain, including the complexity of kinase networks, blood–brain barrier permeability and the lack of robust biomarkers. Emerging technologies, such as covalent inhibitors, targeted protein degradation and combination therapies, offer new avenues for addressing these challenges and developing more effective treatments for neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesProtein KinasesHumansAnimalsProtein Kinase Inhibitors

Stichwörter der Autor:innen

Alzheimer's diseaseHuntington's diseaseParkinson's diseaseneurodegenerative diseasesprotein kinasestau phosphorylation

Substanzen

Protein KinasesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India.
  • Integral Institute of Medical Sciences and Research, Integral University, Lucknow, Uttar Pradesh, India.
  • School of Pharmaceutical Sciences, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India.

ORCID-Profile: Anas Islam

Zitieren

APA

Naim, A., Farooqui, A. M., Badruddeen, Khan, M. I., Akhtar, J., Ahmad, A., & Islam, A. (2025). The Role of Kinases in Neurodegenerative Diseases: From Pathogenesis to Treatment. European Journal of Neuroscience, 61(11). https://doi.org/10.1111/ejn.70156

Vancouver

Naim A, Farooqui AM, Badruddeen, Khan MI, Akhtar J, Ahmad A, et al. The Role of Kinases in Neurodegenerative Diseases: From Pathogenesis to Treatment. European Journal of Neuroscience. 2025;61(11). doi:10.1111/ejn.70156

BibTeX
@article{Naim2025,
  author = {Naim, Alkusha and Farooqui, Azhar Mahmood and Badruddeen and Khan, Mohammad Irfan and Akhtar, Juber and Ahmad, Asad and Islam, Anas},
  title = {The Role of Kinases in Neurodegenerative Diseases: From Pathogenesis to Treatment},
  journal = {European Journal of Neuroscience},
  year = {2025},
  volume = {61},
  number = {11},
  doi = {10.1111/ejn.70156}
}
Kostenlos starten →